Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy. 1976

G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut

Four mycobacterial extracts--two water soluble and two water insoluble--were tested for their immunostimulatory and antitumor activities: MER, the methanol extraction residue fraction of tubercle bacilli (insoluble); HIU I, an insoluble component of the membrane of whole cells of bacillus Calmette-Guérin (BCG); HIU II, a soluble component of BCG; AND Lederer's WSA, a soluble extract of Mycobacterium smegmatis. In a hemolytic plaque-forming cell assay, MER, HIU II and WSA showed immunostimulatory activity. However, only MER was active in the immunoprophylaxis of L1210 leukemia and of the solid Lewis tumor. The loss of antitumor activity does not seem to be related to water solubility, but appears rather to occur during purification.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000432 Methanol A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness. Alcohol, Methyl,Carbinol,Sodium Methoxide,Wood Alcohol,Alcohol, Wood,Methoxide, Sodium,Methyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
January 1956, The Journal of experimental medicine,
G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
May 1956, American review of tuberculosis,
G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
January 1975, Immunological communications,
G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
May 1976, The Medical clinics of North America,
G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
June 1978, The Nursing clinics of North America,
G Mathé, and I J Hiu, and O Halle-Pannenko, and C Bourut
January 1977, Cancer treatment reports,
Copied contents to your clipboard!